GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » 5-Year Yield-on-Cost %

Ryvu Therapeutics (WAR:RVU) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 28, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics 5-Year Yield-on-Cost %?

Ryvu Therapeutics's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Ryvu Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:



WAR:RVU's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.705
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Ryvu Therapeutics's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Ryvu Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryvu Therapeutics's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ryvu Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Ryvu Therapeutics's 5-Year Yield-on-Cost % falls into.


;
;

Ryvu Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Ryvu Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Ryvu Therapeutics  (WAR:RVU) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Ryvu Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryvu Therapeutics Business Description

Traded in Other Exchanges
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines